BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31063128)

  • 1. An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma.
    Turnham RE; Smith FD; Kenerson HL; Omar MH; Golkowski M; Garcia I; Bauer R; Lau HT; Sullivan KM; Langeberg LK; Ong SE; Riehle KJ; Yeung RS; Scott JD
    Elife; 2019 May; 8():. PubMed ID: 31063128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.
    Lauer SM; Omar MH; Golkowski MG; Kenerson HL; Pascual BC; Forbush K; Smith FD; Gordan J; Ong SE; Yeung RS; Scott JD
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the chimeric DnaJ-PKAc enzyme by endogenous inhibitor proteins.
    Averill AM; Rehman HT; Charles JW; Dinh TA; Danyal K; Verschraegen CF; Stein GS; Dostmann WR; Ramsey JE
    J Cell Biochem; 2019 Aug; 120(8):13783-13791. PubMed ID: 30938854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.
    Lauer SM; Omar MH; Golkowski MG; Kenerson HL; Lee KS; Pascual BC; Lim HC; Forbush K; Smith FD; Gordan JD; Ong SE; Yeung RS; Scott JD
    Cell Rep; 2024 Feb; 43(2):113678. PubMed ID: 38236773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system.
    Rinaldi L; Delle Donne R; Catalanotti B; Torres-Quesada O; Enzler F; Moraca F; Nisticò R; Chiuso F; Piccinin S; Bachmann V; Lindner HH; Garbi C; Scorziello A; Russo NA; Synofzik M; Stelzl U; Annunziato L; Stefan E; Feliciello A
    Nat Commun; 2019 Jun; 10(1):2572. PubMed ID: 31189917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma.
    Lu TW; Aoto PC; Weng JH; Nielsen C; Cash JN; Hall J; Zhang P; Simon SM; Cianfrocco MA; Taylor SS
    PLoS Biol; 2020 Dec; 18(12):e3001018. PubMed ID: 33370777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DnaJ-PKAc fusion induces liver inflammation in a zebrafish model of fibrolamellar carcinoma.
    de Oliveira S; Houseright RA; Korte BG; Huttenlocher A
    Dis Model Mech; 2020 Apr; 13(4):. PubMed ID: 32102783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma.
    Tomasini MD; Wang Y; Karamafrooz A; Li G; Beuming T; Gao J; Taylor SS; Veglia G; Simon SM
    Sci Rep; 2018 Jan; 8(1):720. PubMed ID: 29335433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
    Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A framework for fibrolamellar carcinoma research and clinical trials.
    Dinh TA; Utria AF; Barry KC; Ma R; Abou-Alfa GK; Gordan JD; Jaffee EM; Scott JD; Zucman-Rossi J; O'Neill AF; Furth ME; Sethupathy P
    Nat Rev Gastroenterol Hepatol; 2022 May; 19(5):328-342. PubMed ID: 35190728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma.
    Riehle KJ; Kenerson HL; Riggle KM; Turnham R; Sullivan K; Bauer R; Scott JD; Yeung RS
    Oncotarget; 2019 Aug; 10(49):5092-5102. PubMed ID: 31489118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.
    Chan GKL; Maisel S; Hwang YC; Pascual BC; Wolber RRB; Vu P; Patra KC; Bouhaddou M; Kenerson HL; Lim HC; Long D; Yeung RS; Sethupathy P; Swaney DL; Krogan NJ; Turnham RE; Riehle KJ; Scott JD; Bardeesy N; Gordan JD
    Elife; 2023 Jan; 12():. PubMed ID: 36692000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique genomic profile of fibrolamellar hepatocellular carcinoma.
    Cornella H; Alsinet C; Sayols S; Zhang Z; Hao K; Cabellos L; Hoshida Y; Villanueva A; Thung S; Ward SC; Rodriguez-Carunchio L; Vila-Casadesús M; Imbeaud S; Lachenmayer A; Quaglia A; Nagorney DM; Minguez B; Carrilho F; Roberts LR; Waxman S; Mazzaferro V; Schwartz M; Esteller M; Heaton ND; Zucman-Rossi J; Llovet JM
    Gastroenterology; 2015 Apr; 148(4):806-18.e10. PubMed ID: 25557953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.
    Honeyman JN; Simon EP; Robine N; Chiaroni-Clarke R; Darcy DG; Lim II; Gleason CE; Murphy JM; Rosenberg BR; Teegan L; Takacs CN; Botero S; Belote R; Germer S; Emde AK; Vacic V; Bhanot U; LaQuaglia MP; Simon SM
    Science; 2014 Feb; 343(6174):1010-4. PubMed ID: 24578576
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNAJ Proteins in neurodegeneration: essential and protective factors.
    Zarouchlioti C; Parfitt DA; Li W; Gittings LM; Cheetham ME
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA.
    Neumayer C; Ng D; Jiang CS; Qureshi A; Lalazar G; Vaughan R; Simon SM
    Clin Cancer Res; 2023 Jan; 29(1):271-278. PubMed ID: 36302174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70.
    Cheng H; Cenciarelli C; Shao Z; Vidal M; Parks WP; Pagano M; Cheng-Mayer C
    Curr Biol; 2001 Nov; 11(22):1771-5. PubMed ID: 11719219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial metastasis in fibrolamellar hepatocellular carcinoma.
    Hammond WJ; Lalazar G; Saltsman JA; Farber BA; Danzer E; Sherpa TC; Banda CD; Andolina JR; Karimi S; Brennan CW; Torbenson MS; La Quaglia MP; Simon SM
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.